NIOSH and other federal agencies are taking comment on separate efforts to assess the risks of 1-Bromopropane (1-BP), a widely used chemical solvent, assessments that could open the door to new regulatory mandates to limit risks to workers and pregnant women that may be vulnerable to the chemical's adverse effects.
